Drug Information

Drug General Information
Drug ID
D0X9WC
Former ID
DIB006762
Drug Name
ISIS-DMPK
Drug Type
Antisense drug
Indication Myotonic dystrophy [ICD10:G71.1] Phase 1/2 [525022]
Target and Pathway
Target(s) mRNA of DMPK Target Info [551943]
References
Ref 525022ClinicalTrials.gov (NCT02312011) A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1. U.S. National Institutes of Health.
Ref 551943Clinical pipeline report, company report or official report of ISIS Pharmaceuticals.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.